Tricyclic compounds with OMA1/OPA1 modulatory properties
Assignee712 North Inc.
InventorMarcel Victor Alavi Khorassani Moghadam
Life of this patent
Estimating the term…
Abstract
Tricyclic compounds, and in particular novel dibenzoxazepin derivates are disclosed herein, which were quite surprisingly found as having OMA1 and/or OPA1 modulatory properties. Compounds of present invention may provide useful for the treatment of certain conditions and diseases, which are amenable to OMA1 and/or OPA1-modulatory therapies. Such conditions may include conditions and diseases prevalent in the elderly, including cancer. Pharmaceutical compositions comprising compounds of present invention may be combined with other treatments or further comprise other pharmaceutically active ingredients.
Claims14
A compound of formula (I)
- or a stereochemical isomeric form thereof, wherein
- A is an alkyl, alkylene, alkenyl, alkynyl, alkylidene, —N(H)—, —N(R11)—, —N(OH)—, —S(O)2—, —S(O)—, —O—, or the like;
- B is C, N, O, P, or S provided that when B represents N or O then B may or may not be substituted at R6;
- R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, or R12 is hydrogen, halo, hydroxy, carboxy, keto, alkyl, alkylene, haloalkyl, polyhaloalkyl, haloalkoxy, nitrile, carbocyclic residue, aryl, aryloxy, arylamino, arylalkylamino, arylthio, arylalkanoylamino, arylsulfonyl, arylalkoxy, arylsulfinyl, arylheteroaryl, arylalkylthio, arylcarbonyl, arylalkenyl, or arylalkylsulfonyl, alkynyl, alkenyl, alkyloxy, polyhaloalkyloxy, alkylidene, cycloalkyl, cycloalkanone, heterocyclic group, heteroaryl, —C(O)OR12, —NR13R14, —C(O)NR13R14 or the like, wherein NR13R14 may form a heterocyclic ring, or a chemical group;
- and wherein at least one of R1, R2, R3, R4, R7, R8, R9, or R10 is a group of formula (II)
- or a stereochemical isomeric form thereof, wherein
- A′ is a sulfonyl group (—S(O)2—);
- B′ is N, O, P or S;
- and
- R′1 or R′2 is hydrogen, halo, hydroxy, carboxy, keto, alkyl, alkylene, haloalkyl, polyhaloalkyl, haloalkoxy, nitrile, carbocyclic residue, aryl, aryloxy, arylamino, arylalkylamino, arylthio, arylalkanoylamino, arylsulfonyl, arylalkoxy, arylsulfinyl, arylheteroaryl, arylalkylthio, arylcarbonyl, arylalkenyl, or arylalkylsulfonyl, alkynyl, alkenyl, alkyloxy, polyhaloalkyloxy, alkylidene, cycloalkyl, cycloalkanone, heterocyclic group, heteroaryl, —C(O)OR12, —NR13R14, —C(O)NR13R14 or the like, wherein NR13R14 may form a heterocyclic ring, or a chemical group;
- or a pharmaceutically acceptable salt thereof, or an N-oxide thereof.
Dependencies are inferred from the claim text.